| Patent Number |
Title Of Patent |
Date Issued |
| 7514225 |
Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
April 7, 2009 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7435737 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
October 14, 2008 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7432374 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
October 7, 2008 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7365200 |
Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
April 29, 2008 |
| Inhibitors of macrophage migration inhibitory factor having a thienopyridinone backbone are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with macrophage migration inhibitory factor activity. The |
| 7361760 |
Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor an |
April 22, 2008 |
| Inhibitors of MIF having a naphthyridine backbone are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including |
| 7312221 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
December 25, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7312220 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
December 25, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7238809 |
Process for the preparation of inhibitors of macrophage migration inhibitory factor |
July 3, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7235565 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
June 26, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7235546 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
June 26, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7230106 |
Process for the preparation of inhibitors of macrophage migration inhibitory factor |
June 12, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7202248 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
April 10, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7192961 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
March 20, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7173036 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
February 6, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7157469 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
January 2, 2007 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7129236 |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
October 31, 2006 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## including stereoisomers, prodrugs and phar |
| 7084141 |
Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
August 1, 2006 |
| Inhibitors of MIF are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with MIF activity. The inhibitors of MIF have the following structures: ##STR00001## ##STR00002## including stereoisomers, prodrug |
